These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23551924)

  • 21. Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials.
    Dold M; Li C; Gillies D; Leucht S
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):1023-33. PubMed ID: 23602690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipsychotic augmentation with modafinil or armodafinil for negative symptoms of schizophrenia: systematic review and meta-analysis of randomized controlled trials.
    Andrade C; Kisely S; Monteiro I; Rao S
    J Psychiatr Res; 2015 Jan; 60():14-21. PubMed ID: 25306261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis.
    Helfer B; Samara MT; Huhn M; Klupp E; Leucht C; Zhu Y; Engel RR; Leucht S
    Am J Psychiatry; 2016 Sep; 173(9):876-86. PubMed ID: 27282362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
    Zheng W; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Sun F; D'Arcy C; Meng X; Xiang YT
    Hum Psychopharmacol; 2016 Jul; 31(4):286-95. PubMed ID: 27302211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
    Dold M; Samara MT; Li C; Tardy M; Leucht S
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?
    Bantick RA; Deakin JF; Grasby PM
    J Psychopharmacol; 2001 Mar; 15(1):37-46. PubMed ID: 11277607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials.
    Xiang YQ; Zheng W; Wang SB; Yang XH; Cai DB; Ng CH; Ungvari GS; Kelly DL; Xu WY; Xiang YT
    Eur Neuropsychopharmacol; 2017 Jan; 27(1):8-18. PubMed ID: 27919523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cariprazine for the Treatment of Schizophrenia: A Review of this Dopamine D3-Preferring D3/D2 Receptor Partial Agonist.
    Citrome L
    Clin Schizophr Relat Psychoses; 2016; 10(2):109-19. PubMed ID: 27440212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-treatment of buspirone with atypical antipsychotic drugs (AAPDs) improved neurocognitive function in chronic schizophrenia.
    Wang Y; Yang X; Song X; Zhao L; Wei J; Wang J; Tian H; Zheng C; Wei M; Wang Q; Guo W; Deng W; Li T; Ma X
    Schizophr Res; 2019 Jul; 209():135-140. PubMed ID: 31101513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Cai DB; Yang XH; Ungvari GS; Ng CH; Müller N; Ning YP; Xiang YT
    J Psychiatr Res; 2017 Sep; 92():139-146. PubMed ID: 28445800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amantadine for Antipsychotic-Related Weight Gain: Meta-Analysis of Randomized Placebo-Controlled Trials.
    Zheng W; Wang S; Ungvari GS; Ng CH; Yang XH; Gu YH; Li M; Xiang YQ; Xiang YT
    J Clin Psychopharmacol; 2017 Jun; 37(3):341-346. PubMed ID: 28383359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of adjunctive D-Cycloserine for the treatment of schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
    Kuppili PP; Menon V; Sathyanarayanan G; Sarkar S; Andrade C
    J Neural Transm (Vienna); 2021 Feb; 128(2):253-262. PubMed ID: 33439362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.
    McRae-Clark AL; Baker NL; Gray KM; Killeen TK; Wagner AM; Brady KT; DeVane CL; Norton J
    Drug Alcohol Depend; 2015 Nov; 156():29-37. PubMed ID: 26386827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augmentation with buspirone: a review.
    Harvey KV; Balon R
    Ann Clin Psychiatry; 1995 Sep; 7(3):143-7. PubMed ID: 8646275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine partial agonists and prodopaminergic drugs for schizophrenia: Systematic review and meta-analysis of randomized controlled trials.
    Osugo M; Whitehurst T; Shatalina E; Townsend L; O'Brien O; Mak TLA; McCutcheon R; Howes O
    Neurosci Biobehav Rev; 2022 Apr; 135():104568. PubMed ID: 35131396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
    Okuyama Y; Oya K; Matsunaga S; Kishi T; Iwata N
    Neuropsychiatr Dis Treat; 2016; 12():3221-3236. PubMed ID: 28008259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia.
    Sumiyoshi T; Matsui M; Yamashita I; Nohara S; Kurachi M; Uehara T; Sumiyoshi S; Sumiyoshi C; Meltzer HY
    Biol Psychiatry; 2001 May; 49(10):861-8. PubMed ID: 11343682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memantine as an Augmentation Treatment for Schizophrenia: Limitations of Meta-Analysis for Evidence-Based Evaluation of Research.
    Andrade C
    J Clin Psychiatry; 2017; 78(9):e1307-e1309. PubMed ID: 29178686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.